tert-Butyl 2-cyclopropyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate

Catalog No.: 
ACXIVX839
CAS No.: 
1779126-43-0
Molecular Formula: 
C15H23N3O3
Molecular Weight: 
293.37
tert-Butyl 2-cyclopropyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg99%$327.00InquiryInquiry
100mg99%$488.00InquiryInquiry
250mg99%$957.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-cyclopropyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate
IUPAC Nametert-butyl 2-cyclopropyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate
MDL No.MFCD26097121
Molecular FormulaC15H23N3O3
Molecular Weight293.37
SMILESO=C(N(CC1)CCC1(N=C(C2CC2)N3)C3=O)OC(C)(C)C
InChI KeyLZLLDQCAAFHWTM-UHFFFAOYSA-N
Synonymtert-Butyl 2-cyclopropyl-4-oxo-1,3,8-triazaspiro[4.5]dec-1-ene-8-carboxylate;1,3,8-Triazaspiro[4.5]dec-1-ene-8-carboxylic acid, 2-cyclopropyl-4-oxo-, 1,1-dimethylethyl ester
CAS No.1779126-43-0

Synthetic Route by SureRoute

1. ACXIVX839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQNU854 route compound structure diagram
    ACAQNU854411235-57-9In Stock
  4. Then
  5. ACXIVX839 route product structure diagram
    ACXIVX8391779126-43-0
Inquiry

2. ACXIVX839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXIVX839 route product structure diagram
    ACXIVX8391779126-43-0
Inquiry

3. ACXIVX839 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXIVX839 route product structure diagram
    ACXIVX8391779126-43-0
Inquiry

Comments (0)